Toxic Neuropathies Associated with Pharmaceutic and Industrial Agents - 09/08/11
Doi : 10.1016/j.ncl.2006.10.001
Zachary London, MD, James W. Albers, MD, PhD ⁎ 
Department of Neurology, University of Michigan, 1324 Taubman Center, Ann Arbor, MI 48109-0322, USA
Corresponding author.Plan
| Dr. Albers has received personal compensation from Eli Lily and Co. for consulting and for serving on a scientific advisory board, and he has a research grant from the National Institutes of Health and a research contract from the US Air Force. He previously received research grants from Dow AgroSciences, Dow Chemical Co., Prana Biotechnology, and CSX Transportation. Dr. Albers also has been retained as a consultant to firms or companies concerned with the manufacture or use of toxic substances, including medications, solvents, metals, and pesticides. Support of these activities has included personal and institutional remuneration. Portions of this article rely on materials reproduced from: Albers JW, Teener JW. Toxic neuropathies. In: Kimura J, editor. Peripheral nerve diseases. Handbook of clinical neurophysiology. Vol. 7. Philadelphia: Elsevier; 2006. p. 677–702; Albers JW, Wald JJ. Industrial and environmental toxic neuropathies. In: Brown WF, editor. Neuromuscular function and disease: basic, clinical, and electrodiagnostic aspects. Philadelphia: WB Saunders; 2002. p. 1143–68; and Albers JW. Toxic neuropathies. Continuum: lifelong learning in neurology neurotoxicology 1999;5:27–50. |
© 2007
Elsevier Inc. Tous droits réservés.
Vol 25 - N° 1
P. 257-276 - février 2007 Retour au numéro
Article précédent
- Nutritional Neuropathies
- Neeraj Kumar
- Autonomic Peripheral Neuropathy
- Roy Freeman
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?